Header Logo

Connection

Dinesh Yogaratnam to Omalizumab

Back to Details
This is a "connection" page, showing publications Dinesh Yogaratnam has written about Omalizumab.
Dinesh Yogaratnam
Connection Strength
0.961
Omalizumab
  1. Yogaratnam D, Mukherjee SM, Getchell K, Dima L. Omalizumab: First Approved Anti-IgE Therapy for Multiple Food Allergies. Am J Ther. 2026 Jan-Feb 01; 33(1):e39-e45.
    View in: PubMed
    Score: 0.961
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.